Kite

NHS and Kite sign access deal for Kite’s cancer cell therapy Tecartus

https://pharmaphorum.com/news/nhs-kite-cancer-therapy/

Why cell therapy manufacture is a team sport

https://pharmaphorum.com/market-access-2/why-cell-therapy-manufacture-is-a-team-sport/

Gilead poaches oncology expert Quigley from BMS

https://pharmaphorum.com/news/gilead-poaches-oncology-expert-quigley-from-bms/

CAR-TCR Summit Europe

https://pharmaphorum.com/events/car-tcr-summit-europe/

Delivering innovative therapies with close industry-NHS partnerships

https://pharmaphorum.com/r-d/views-analysis-r-d/delivering-innovative-therapies-with-close-industry-nhs-partnerships/

Gilead highlights Yescarta survival data in ASCO update

https://pharmaphorum.com/news/gilead-highlights-yescarta-survival-data-in-asco-update/

Gilead develops solid tumour cell therapy with Gadeta

https://pharmaphorum.com/news/gilead-develops-solid-tumour-cell-therapy-with-gadeta/

Kite expands manufacturing capacity for CAR-T therapies

https://pharmaphorum.com/news/kite-expands-manufacturing-capacity-for-car-t-therapies/

Kite and Sangamo come together in $3bn cancer gene editing alliance

https://pharmaphorum.com/views-analysis-oncology/kite-sangamo-come-together-3bn-cancer-gene-editing-alliance/

1 2

Close in 10 seconds

Pharmaphorum.com

Search